We’re thrilled to share that we're expanding our licensing agreement with Quanterix to advance next generation Alzheimer's disease biomarker research.
🔗Read the full announcement: alzpath.bio/alzpath-and-...
@alzpath.bsky.socialExplore
@alzpath.bsky.social
@newsen.bsky.socialALZpath and Quanterix Join Forces to Enhance Alzheimer's Research with Expanded Licensing Agreement #United_States #Alzheimer's #Carlsbad #Quanterix #ALZpath